Dr. David Agus

 Dr. David B. Agus is a professor of medicine and engineering at the University of Southern California Keck School of Medicine and Viterbi School of Engineering and the founding director of USC’s Lawrence J. Ellison Institute for Transformative Medicine. He is one of the world’s leading physicians and the cofounder of several pioneering personalized medicine companies. Over the past twenty-five years he’s received acclaim for his innovations in medicine and contributions to new technologies and therapeutics that change how all of us maintain optimal health and treat cancer. As a contributor to CBS News, he comments on important health topics regularly on television. Dr. Agus specializes in treating patients with advanced cancer. His clinical responsibilities include the development of clinical trials for new drugs and treatments for cancer, supported by the National Cancer Institute and other private foundations (he has no financial ties to drug companies). He serves in leadership roles at the World Economic Forum, among other prestigious organizations. After earning his Bachelor of Arts in Molecular Biology from Princeton University and medical degree from the University of Pennsylvania School of Medicine, he completed his medical residency training at Johns Hopkins Hospital, a research fellowship at the National Institutes of Health, and an Oncology fellowship at the Memorial Sloan-Kettering Cancer Center. He is a 2017 recipient of the Ellis Island Medal of Honor.

Displaying stories 1-3 of 3 in total

Dr. David Agus On His Joy Trigger and Prioritizing Sleep

by Dr. David Agus
Getty Images

To Take Care of Patients, Health Care Providers and Researchers Must Take Care of Themselves

by Arianna Huffington, Dr. David Agus
Work Smarter//

Why We Need Corporate Well-Being Programs More Than Ever

by Dr. David Agus
We use cookies on our site to give you the best experience possible. By continuing to browse the site, you agree to this use. For more information on how we use cookies, see our Privacy Policy.